Bactiquant A/S
Bactiquant A/S has a high price-to-book ratio of 7.17, indicating that the market values the company significantly above its book value. The company's liquidity position is strong, with a current ratio of 6.02, suggesting it has ample short-term assets to cover its liabilities. However, the company's operating cash flow is negative at -10,508,000 DKK, and its free cash flow is also negative at -12,257,120 DKK, indicating that it is not generating positive cash from operations. The company's profitability is weak, with a return on equity of -0.8014 and a return on assets of -0.4928, both significantly below the industry median. The gross profit is negative at -2,192,640 DKK, and the operating income is also negative at -12,497,520 DKK, indicating that the company is not yet profitable. Bactiquant A/S operates through seven business segments, including Aquaculture, Water Utility, Industry, Data Centres, Oil and Gas, Legionella Risk Assessment, and Research Institutions. The company serves customers across five continents, with a focus on public water utility companies and industries requiring water cooling or wastewater treatment. However, the revenue concentration data is not available, so it is unclear if the company is overly reliant on any particular segment or geographic region. The company's growth trajectory is uncertain, as the outlook for the current fiscal year and the next fiscal year is not provided. The company's revenue has not been provided for previous years, so it is difficult to assess its historical growth. However, the company's market cap of 123,822,124.8 DKK suggests that the market has some optimism about its future potential. The risk assessment indicates that the company has low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The debt-to-equity ratio is 0.5, indicating a moderate level of leverage. The company's capital structure is relatively strong, with total equity of 17,260,620 DKK and total liabilities of 10,807,680 DKK. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's recent financial performance is characterized by negative operating and net income, but its strong cash and equivalents position of 17,867,810 DKK provides a buffer against short-term liquidity risks.
Business. Bactiquant A/S develops technology to monitor bacterial contamination levels in water, serving industries such as public water utilities, aquaculture, and industrial water treatment.
Classification. Bactiquant A/S is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a confidence level of 0.92.
- Bactiquant A/S has a high price-to-book ratio of 7.17, indicating that the market values the company significantly above its book value.
- The company's profitability is weak, with a return on equity of -0.8014 and a return on assets of -0.4928.
- Bactiquant A/S operates through seven business segments, including Aquaculture, Water Utility, and Industry, serving customers across five continents.
- The company's growth trajectory is uncertain, as the outlook for the current and next fiscal years is not provided.
- The risk assessment indicates that the company has low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected.
- --
- ## RATIONALES
- ```json
- No immediate filing-based liquidity or dilution flags were detected.